论文部分内容阅读
目的寻求治疗社区老年心律失常的有效方法,观察参松养心胶囊联合倍他乐克治疗社区老年心律失常的疗效,提高社区老年心律失常患者的生活质量。方法选择社区门诊老年心律失常患者120例,随机分为治疗组和对照组,各60例;治疗组口服参松养心胶囊,4粒/次,3次/d,同时口服倍他乐克,25 mg/次,2次/d;对照组口服倍他乐克,25mg/次,2次/d;两组均治疗4周,观察治疗后临床症状和心电图的改善情况。结果疗程结束后,治疗组临床症状改善总有效率以及心律失常改善总有效率与对照组相比差异均具有统计学意义(P<0.01),临床效果明显优于对照组,且未发现任何不良反应。结论参松养心胶囊联合倍他乐克对老年心律失常具有显著的疗效,并且安全、可靠,可以显著提高患者的生活质量,避免了西药本身致心律失常的作用,值得进一步推广应用。
Objective To seek an effective method to treat elderly patients with arrhythmia in the community and observe the effect of Shensong Yangxin Capsule combined with Betaloc in the treatment of elderly patients with arrhythmia in the community and to improve the quality of life of elderly patients with arrhythmia in the community. Methods A total of 120 elderly patients with arrhythmia in community outpatient department were randomly divided into treatment group (60 cases) and control group (60 cases). The treatment group was given Shensongyangxin Capsule (4 tablets / time, 3 times / d) 25 mg / time, 2 times / d. The control group was treated with metoprolol 25 mg twice daily for 4 weeks. The improvement of clinical symptoms and electrocardiogram was observed after treatment. Results After treatment, the total effective rate of clinical symptom improvement and the total effective rate of arrhythmia improvement in the treatment group were significantly different from those in the control group (P <0.01). The clinical effect was obviously superior to that of the control group, and no adverse reactions were found reaction. Conclusion Shensong Yangxin Capsule combined with Betaloc has a significant effect on the arrhythmia in the elderly and is safe and reliable. It can significantly improve the quality of life of the patients and avoid the arrhythmia caused by the western medicine itself, which is worth further promotion and application.